(Q43708647)

English

Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Helicobacter pylori

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Sotirios D Georgopoulos

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Elias Xirouchakis

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Beatriz Martinez-Gonzalez

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Dionyssios N Sgouras

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Charikleia Spiliadi

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Andreas F Mentis

6

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Fotini Laoudi

7

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

publication date

29 May 2013

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

459-467

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Clinical practice. Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12062

21 January 2018

American College of Gastroenterology guideline on the management of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12062

21 January 2018

Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12062

21 January 2018

Helicobacter pylori treatment in the era of increasing antibiotic resistance

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12062

21 January 2018

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12062

21 January 2018

A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE Study

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12062

21 January 2018

One-week triple vs. quadruple therapy for Helicobacter pylori infection - a randomized trial.

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12062

21 January 2018

Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12062

21 January 2018

Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12062

21 January 2018

Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori.

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12062

21 January 2018

14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12062

21 January 2018

The status of antimicrobial resistance of Helicobacter pylori in eastern Europe.

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12062

21 January 2018

Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12062

21 January 2018

Omeprazole triple therapy versus omeprazole quadruple therapy for healing duodenal ulcer and eradication of Helicobacter pylori infection: a 24-month follow-up study

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12062

21 January 2018

Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12062

21 January 2018

Effectiveness of two quadruple, tetracycline- or clarithromycin-containing, second-line, Helicobacter pylori eradication therapies

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12062

21 January 2018

Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12062

21 January 2018

Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12062

21 January 2018

Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12062

21 January 2018

Risk factors for failure of Helicobacter pylori therapy--results of an individual data analysis of 2751 patients

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12062

21 January 2018

Sequential therapy in clarithromycin-sensitive and -resistant Helicobacter pylori based on polymerase chain reaction molecular test

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12062

21 January 2018

Ten-day sequential therapy of Helicobacter pylori infection in Thailand

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12062

21 January 2018

Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12062

21 January 2018

Dual proton pump inhibitor plus amoxicillin as an empiric anti-H. pylori therapy: studies from the United States

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12062

21 January 2018

The effects of varying acidity on Helicobacter pylori growth and the bactericidal efficacy of ampicillin

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12062

21 January 2018

Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design.

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12062

21 January 2018

Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure.

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12062

21 January 2018

Pilot studies to identify the optimum duration of concomitant Helicobacter pylori eradication therapy in Thailand.

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12062

21 January 2018

Comparison of the Etest and the NCCLS-approved agar dilution method to detect metronidazole and clarithromycin resistant Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12062

21 January 2018

Identifiers

10.1111/HEL.12062

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43708647&oldid=2102729004"